Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors-Reference-Cited by-同舟云学术

Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors

Published:2018-10-16 Issue:3 Volume:123 Page:519-529
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Hackett Geoffrey¹²^ORCID,Cole Nigel¹,Mulay Akhilesh³,Strange Richard C.⁴,Ramachandran Sudarshan⁵⁶

Affiliation:

1. Department of Urology; University Hospitals Birmingham NHS Foundation Trust; Birmingham UK

2. School of Health and Life Sciences; Aston University; Birmingham UK

3. University of Cambridge; Cambridge UK

4. Institute for Science and Technology in Medicine; Keele University Medical School; Stoke-on-Trent UK

5. Department of Clinical Biochemistry; University Hospitals of North Midlands/Faculty of Health Sciences; Staffordshire University; Stoke-on-Trent UK

6. College of Engineering, Design & Physical Sciences; Brunel University London; London UK

Funder

Bayer

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.14536/fullpdf

Reference48 articles.

1. Biochemical hypogonadism and type 2 diabetes in primary care;Hackett;Br J Diabetes Vasc Dis,2009

2. Late-onset hypogonadism and mortality in aging men;Pye;J Clin Endocrinol Metab,2014